Vapor ablation systems and methods
A vapor delivery needle is provided that may include any of a number of features. One feature of the energy delivery probe is that it can apply condensable vapor energy to tissue, such as a prostrate, to shrink, damage, denaturate the prostate. In some embodiments, the vapor delivery needle can be advanced a predetermined distance into the prostate with a solenoid actuation mechanism. Methods associated with use of the energy delivery probe are also covered.
1. A prostate treatment device, comprising: an introducer shaft sized and configured for transurethral access into a patient;
a handle coupled to the introducer shaft;
a vapor generator disposed in the handle and configured to generate a condensable vapor;
a vapor delivery needle in communication with the vapor generator and slidably disposed within the introducer shaft;
a magnet attached to the needle;
a solenoid actuator disposed around the magnet, the solenoid actuator comprising a push winding coupled to a source of RF current and a pull winding coupled to the source of RF current, the push winding being configured to apply a first magnetic field to the magnet, the pull winding being configured to apply a second magnetic field to the magnet, wherein the first and second magnetic fields move a distal tip of the vapor delivery needle between a retracted position inside the introducer shaft and an extended position at least partially outside of the introducer shaft, wherein the vapor delivery needle is offset from a central longitudinal axis of the push winding and the pull winding; and
a power supply configured to supply a first current to the push winding and a second current to the pull winding at a same time, wherein the first current is in a direction opposite to a direction of the second current.
2. The prostate treatment device of claim 1 , wherein the first magnetic field shares a polarity with the magnet.
3. The prostate treatment device of claim 1 , wherein the second magnetic field has a polarity opposite to a polarity of the magnet.
4. The prostate treatment device of claim 1 , wherein a combination of the first and second magnetic fields removes lateral movements of the magnet as the vapor delivery needle moves between the retracted position and the extended position.
5. The prostate treatment device of claim 1 , wherein a combination of the first and second magnetic fields approximately doubles a force exerted by the push and pull windings to the magnet than would be exerted by a single winding.
6. The prostate treatment device of claim 1 , wherein the solenoid actuator is configured to cause the distal tip of the vapor delivery needle to penetrate into prostate tissue when moving toward the extended position from the retracted position.
7. The prostate treatment device of claim 1 , wherein the vapor delivery needle is sized and configured to extend into prostate tissue when the introducer shaft is positioned within a urethra of the patient.
8. The prostate treatment device of claim 1 , wherein the handle is adapted for manual control of the solenoid actuator to move the vapor delivery needle between the retracted position and the extended position.
9. The prostate treatment device of claim 1 , further comprising a vapor actuator configured to actuate a flow of condensable vapor through the vapor delivery needle.
10. The prostate treatment device of claim 1 , wherein the magnet comprises a neodymium-iron-boron magnet.
11. The prostate treatment device of claim 1 , further comprising a magnetic field sensor disposed near the solenoid actuator, the magnetic field sensor being configured to provide a voltage output proportional to a magnetic field produced by the magnet to determine a position of the vapor delivery needle.
12. The prostate treatment device of claim 11 , wherein vapor delivery is prevented if the voltage output of the magnetic field sensor indicates that the vapor delivery needle is not deployed.
13. The prostate treatment device of claim 1 , further comprising a sensor coupled to the push winding and to the pull winding, the sensor being configured to detect back electromagnetic field when the push winding or pull winding is energized with a current source.
14. The prostate treatment device of claim 13 , wherein the back electromagnetic field manifests as a dip in current flowing through the sensor.
15. The prostate treatment device of claim 13 , wherein the back electromagnetic field indicates that the vapor delivery needle has properly deployed into the extended position.
16. A prostate treatment device, comprising:
an introducer shaft sized and configured for transurethral access into a patient;
a handle coupled to the introducer shaft; a vapor generator disposed in the handle and configured to generate a condensable vapor;
a vapor delivery needle in communication with the vapor generator and slidably disposed within the introducer shaft;
a magnet attached to the needle; and
a solenoid actuator disposed around the magnet, the solenoid actuator comprising a push winding coupled to a source of RF current and a pull winding coupled to the source of RF current, the push winding being configured to apply a first magnetic field to the magnet, the pull winding being configured to apply a second magnetic field to the magnet, wherein the first and second magnetic fields move a distal tip of the vapor delivery needle between a retracted position inside the introducer shaft and an extended position at least partially outside of the introducer shaft, wherein the magnet is in the push winding and in the pull winding in the retracted position of the vapor delivery needle, wherein the vapor delivery needle is offset from a central longitudinal axis of the push winding and the pull winding.
17. The prostate treatment device of claim 16 , further comprising a power supply configured to supply a first current to the push winding and a second current to the pull winding at a same time, wherein the first current is in a direction opposite to a direction of the second current.
18. The prostate treatment device of claim 16 , further comprising a magnetic field sensor disposed near the solenoid actuator, the magnetic field sensor being configured to provide a voltage output proportional to a magnetic field produced by the magnet to determine a position of the vapor delivery needle.
19. The prostate treatment device of claim 18 , wherein vapor delivery is prevented if the voltage output of the magnetic field sensor indicates that the vapor delivery needle is not deployed.
20. A prostate treatment device, comprising:
an introducer shaft sized and configured for transurethral access into a patient;
a handle coupled to the introducer shaft;
a vapor generator disposed in the handle and configured to generate a condensable vapor;
a vapor delivery needle in communication with the vapor generator and slidably disposed within the introducer shaft;
a magnet attached to the needle; and
a solenoid actuator disposed around the magnet, the solenoid actuator comprising a push winding coupled to a source of RF current and a pull winding coupled to the source of RF current, the push winding being configured to apply a first magnetic field to the magnet, the pull winding being configured to apply a second magnetic field to the magnet, wherein the first and second magnetic fields move a distal tip of the vapor delivery needle between a retracted position inside the introducer shaft and an extended position at least partially outside of the introducer shaft, wherein the vapor delivery needle is offset from a central longitudinal axis of the push winding and the pull winding.
21. The prostate treatment device of claim 20 , further comprising a power supply configured to supply a first current to the push winding and a second current to the pull winding at a same time, wherein the first current is in a direction opposite to a direction of the second current.
22. The prostate treatment device of claim 20 , further comprising a magnetic field sensor disposed near the solenoid actuator, the magnetic field sensor being configured to provide a voltage output proportional to a magnetic field produced by the magnet to determine a position of the vapor delivery needle.
23. The prostate treatment device of claim 22 , wherein vapor delivery is prevented if the voltage output of the magnetic field sensor indicates that the vapor delivery needle is not deployed.